Research | NYU Langone Health
Source: https://med.nyu.edu/research
Archived: 2026-04-23 17:14
Research | NYU Langone Health
Research | NYU Langone Health
We use cookies and similar tools to give you the best website experience. By using our site, you accept our
websites privacy policy
.
. Opens in a new tab
Skip to Main Content
Research
Our research helps translate breakthrough biomedical discoveries into effective new treatments.
Share:
Twitter
Facebook
Email
When you type in the search field, a menu appears to select search criteria.
Share:
Twitter
Facebook
Email
Skip sidebar
Research
News, Events & Awards
Office of Science & Research
Scientific Cores & Shared Resources
Technology Opportunities & Ventures
Vilcek Institute of Graduate Biomedical Sciences
Postdoctoral Affairs
At NYU Langone Health, our visionary team is at the forefront of scientific inquiry into pioneering innovations and medical therapies. Empowering clinicians to provide extraordinary care informed by the latest biomedical research is core to our mission.
Our faculty have placed us among the nation’s top research universities receiving National Institutes of Health (NIH) funding. With $815 million in awards in 2021, our scientists are leading multidisciplinary studies that reveal the underlying mechanisms driving health and disease. This included more than $450 million in funding—one of the largest grants in NIH history—to better understand the long-term effects of COVID-19 and develop new approaches to diagnosis and treatment.
As the Clinical Science Core of the NIH’s Researching COVID to Enhance Recovery (RECOVER) initiative, NYU Langone leads the research activities of 35 institutions and 100 researchers nationwide in an effort to examine how many people are affected by COVID in the long term, which treatments contribute to recovery, and why some patients are vulnerable to lingering symptoms while others are not.
Our faculty are leaders in their academic disciplines and part of a proud tradition of medical discoveries that improve lives. Jan T. Vilcek, MD, PhD, professor emeritus of microbiology, co-developed the monoclonal antibody that is the basis for the drug Remicade, now widely used to treat certain chronic inflammatory disorders. Today, the Vilcek Institute of Graduate Biomedical Sciences trains PhD and MD/PhD candidates who come from all over the world to explore today’s most urgent biomedical problems under the mentorship of acclaimed faculty members.
At NYU Langone, our clinicians and researchers carry on the legendary tradition of our alumni, who include Jonas Salk, MD, and Albert Sabin, MD, inventors of the first vaccines for polio, and Saul Krugman, MD, whose research led to the development of vaccines for measles, rubella, and hepatitis B. With many of the world’s leading experts on our faculty, we are guiding the future of biomedical research.
Our Research Faculty
Our long history of renowned researchers includes four Nobel Prize laureates.
Learn More
about Our Research Faculty
Departments and Institutes
Our academic departments and research institutes, centers, and programs are leaders in a diverse array of fields.
Learn More
about Departments and Institutes
By the Numbers
220
laboratories devoted to biomedical research
4
Nobel laureates among our faculty and alumni
16
faculty named among the world’s most-cited researchers
Related News
Brain Support Cells Form Previously Unknown Network
Read Story
Immunotherapy Shows Promise in Patients With Bladder Cancer
Read Story
Immune Changes & Risk of Alzheimer’s & Dementia
Read Story
NYU Langone Neurologists Present at AAN 2026
Read Story
How Do Cancer Cells ‘Learn’ to Resist Treatment?
Read Story
9 Tips for Averting E-Bike Injuries
Read Story
E-Bike Crashes Are Driving More Brain Injuries
Read Story
Study Reveals How Mice Can Quickly Identify Odors
Read Story
Some Phthalates Tied to Millions of Preterm Births Worldwide
Read Story
Identifying Adults Most at Risk of Heat-Related Illness
Read Story
NIH Funds Data Hub to Reduce Reliance on Animal Research
Read Story
Prior Authorization May Hinder Access to Heart Failure Meds
Read Story
Show More
Thank you for printing content from NYU Langone Health. © 2026 NYU Grossman School of Medicine.
Research | NYU Langone Health
We use cookies and similar tools to give you the best website experience. By using our site, you accept our
websites privacy policy
.
. Opens in a new tab
Skip to Main Content
Research
Our research helps translate breakthrough biomedical discoveries into effective new treatments.
Share:
When you type in the search field, a menu appears to select search criteria.
Share:
Skip sidebar
Research
News, Events & Awards
Office of Science & Research
Scientific Cores & Shared Resources
Technology Opportunities & Ventures
Vilcek Institute of Graduate Biomedical Sciences
Postdoctoral Affairs
At NYU Langone Health, our visionary team is at the forefront of scientific inquiry into pioneering innovations and medical therapies. Empowering clinicians to provide extraordinary care informed by the latest biomedical research is core to our mission.
Our faculty have placed us among the nation’s top research universities receiving National Institutes of Health (NIH) funding. With $815 million in awards in 2021, our scientists are leading multidisciplinary studies that reveal the underlying mechanisms driving health and disease. This included more than $450 million in funding—one of the largest grants in NIH history—to better understand the long-term effects of COVID-19 and develop new approaches to diagnosis and treatment.
As the Clinical Science Core of the NIH’s Researching COVID to Enhance Recovery (RECOVER) initiative, NYU Langone leads the research activities of 35 institutions and 100 researchers nationwide in an effort to examine how many people are affected by COVID in the long term, which treatments contribute to recovery, and why some patients are vulnerable to lingering symptoms while others are not.
Our faculty are leaders in their academic disciplines and part of a proud tradition of medical discoveries that improve lives. Jan T. Vilcek, MD, PhD, professor emeritus of microbiology, co-developed the monoclonal antibody that is the basis for the drug Remicade, now widely used to treat certain chronic inflammatory disorders. Today, the Vilcek Institute of Graduate Biomedical Sciences trains PhD and MD/PhD candidates who come from all over the world to explore today’s most urgent biomedical problems under the mentorship of acclaimed faculty members.
At NYU Langone, our clinicians and researchers carry on the legendary tradition of our alumni, who include Jonas Salk, MD, and Albert Sabin, MD, inventors of the first vaccines for polio, and Saul Krugman, MD, whose research led to the development of vaccines for measles, rubella, and hepatitis B. With many of the world’s leading experts on our faculty, we are guiding the future of biomedical research.
Our Research Faculty
Our long history of renowned researchers includes four Nobel Prize laureates.
Learn More
about Our Research Faculty
Departments and Institutes
Our academic departments and research institutes, centers, and programs are leaders in a diverse array of fields.
Learn More
about Departments and Institutes
By the Numbers
220
laboratories devoted to biomedical research
4
Nobel laureates among our faculty and alumni
16
faculty named among the world’s most-cited researchers
Related News
Brain Support Cells Form Previously Unknown Network
Read Story
Immunotherapy Shows Promise in Patients With Bladder Cancer
Read Story
Immune Changes & Risk of Alzheimer’s & Dementia
Read Story
NYU Langone Neurologists Present at AAN 2026
Read Story
How Do Cancer Cells ‘Learn’ to Resist Treatment?
Read Story
9 Tips for Averting E-Bike Injuries
Read Story
E-Bike Crashes Are Driving More Brain Injuries
Read Story
Study Reveals How Mice Can Quickly Identify Odors
Read Story
Some Phthalates Tied to Millions of Preterm Births Worldwide
Read Story
Identifying Adults Most at Risk of Heat-Related Illness
Read Story
NIH Funds Data Hub to Reduce Reliance on Animal Research
Read Story
Prior Authorization May Hinder Access to Heart Failure Meds
Read Story
Show More
Thank you for printing content from NYU Langone Health. © 2026 NYU Grossman School of Medicine.